0001420108-26-000007.txt : 20261019 0001420108-26-000007.hdr.sgml : 20261019 20261019141958 ACCESSION NUMBER: 0001420108-26-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261019 DATE AS OF CHANGE: 20261019 EFFECTIVENESS DATE: 20261019 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Glucose Health, Inc. CENTRAL INDEX KEY: 0001420108 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 901117742 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-601719 FILM NUMBER: 261468587 BUSINESS ADDRESS: STREET 1: 609 SW 8TH STREET, SUITE 600 CITY: BENTONVILLE STATE: AR ZIP: 72712 BUSINESS PHONE: 479-802-3827 MAIL ADDRESS: STREET 1: 609 SW 8TH STREET, SUITE 600 CITY: BENTONVILLE STATE: AR ZIP: 72712 FORMER COMPANY: FORMER CONFORMED NAME: Bio-Solutions Corp. DATE OF NAME CHANGE: 20071203 D 1 primary_doc.xml X0708 D LIVE 0001420108 Glucose Health, Inc. 609 SW 8TH STREET, SUITE 600 BENTONVILLE AR ARKANSAS 72712 479-802-3827 DELAWARE Bio-Solutions Corp. Corporation true John Duffy 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Executive Officer Director Mark Schaftlein 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director Edmund Burke 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director Christopher Jemapete 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director Marc Hatch 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Executive Officer Other Health Care $1 - $1,000,000 06b false 2026-10-05 false true false 0 60000 60000 0 Amount represents accrued unpaid obligation for services rendered satisfied by issuance of restricted shares by Issuer to recipient. false 1 0 0 60000 true Amount represents aggregate accrued obligation for services rendered satisfied by issuance of restricted shares by Issuer to entity owned by executive officer. false Glucose Health, Inc. /s/ John Duffy John Duffy CEO 2026-10-19